We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cardinal Health (CAH) Stock Moves -1.02%: What You Should Know
Read MoreHide Full Article
Cardinal Health (CAH - Free Report) closed at $117.92 in the latest trading session, marking a -1.02% move from the prior day. The stock outperformed the S&P 500, which registered a daily loss of 1.07%. Elsewhere, the Dow saw a downswing of 0.97%, while the tech-heavy Nasdaq depreciated by 1.19%.
The the stock of prescription drug distributor has fallen by 2.54% in the past month, leading the Medical sector's loss of 5.64% and undershooting the S&P 500's loss of 0.36%.
Analysts and investors alike will be keeping a close eye on the performance of Cardinal Health in its upcoming earnings disclosure. The company's earnings report is set to go public on January 30, 2025. On that day, Cardinal Health is projected to report earnings of $1.74 per share, which would represent a year-over-year decline of 4.4%. Simultaneously, our latest consensus estimate expects the revenue to be $54.84 billion, showing a 4.53% drop compared to the year-ago quarter.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $7.82 per share and revenue of $219.02 billion, indicating changes of +3.85% and -3.51%, respectively, compared to the previous year.
Any recent changes to analyst estimates for Cardinal Health should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Cardinal Health is currently a Zacks Rank #2 (Buy).
In the context of valuation, Cardinal Health is at present trading with a Forward P/E ratio of 15.24. This denotes a discount relative to the industry's average Forward P/E of 17.62.
Also, we should mention that CAH has a PEG ratio of 1.49. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - Dental Supplies industry had an average PEG ratio of 2.12 as trading concluded yesterday.
The Medical - Dental Supplies industry is part of the Medical sector. This group has a Zacks Industry Rank of 72, putting it in the top 29% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cardinal Health (CAH) Stock Moves -1.02%: What You Should Know
Cardinal Health (CAH - Free Report) closed at $117.92 in the latest trading session, marking a -1.02% move from the prior day. The stock outperformed the S&P 500, which registered a daily loss of 1.07%. Elsewhere, the Dow saw a downswing of 0.97%, while the tech-heavy Nasdaq depreciated by 1.19%.
The the stock of prescription drug distributor has fallen by 2.54% in the past month, leading the Medical sector's loss of 5.64% and undershooting the S&P 500's loss of 0.36%.
Analysts and investors alike will be keeping a close eye on the performance of Cardinal Health in its upcoming earnings disclosure. The company's earnings report is set to go public on January 30, 2025. On that day, Cardinal Health is projected to report earnings of $1.74 per share, which would represent a year-over-year decline of 4.4%. Simultaneously, our latest consensus estimate expects the revenue to be $54.84 billion, showing a 4.53% drop compared to the year-ago quarter.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $7.82 per share and revenue of $219.02 billion, indicating changes of +3.85% and -3.51%, respectively, compared to the previous year.
Any recent changes to analyst estimates for Cardinal Health should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Cardinal Health is currently a Zacks Rank #2 (Buy).
In the context of valuation, Cardinal Health is at present trading with a Forward P/E ratio of 15.24. This denotes a discount relative to the industry's average Forward P/E of 17.62.
Also, we should mention that CAH has a PEG ratio of 1.49. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - Dental Supplies industry had an average PEG ratio of 2.12 as trading concluded yesterday.
The Medical - Dental Supplies industry is part of the Medical sector. This group has a Zacks Industry Rank of 72, putting it in the top 29% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.